SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- Lupus/Nephritis
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: nigel bates11/25/2008 9:07:10 AM
   of 95
 
FcgammaRIIa (mice...)

HONG KONG (Reuters) – Researchers in Australia have designed a drug which appears effective in treating arthritis in mice, and they hope it can be used to treat diseases like rheumatoid arthritis and lupus in people.
In an article published in Immunology and Cell Biology, the scientists said they zeroed in on a certain human receptor, FcgammaRIIa, which appears to be linked to the development of auto-immune diseases like rheumatoid arthritis and lupus.
Using the structure of the receptor, they designed small chemical molecules that blocked the workings of the receptor.
They went on to test the molecules in laboratory mice which carried the human receptor, making them very susceptible to these inflammatory diseases. The molecules appeared to work better than two other commonly-used drugs.
"The team find that the new drug suppresses disease for longer than either of the current commonly-used drugs - methotrexate and anti-CD3," the researchers wrote...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News